|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-3-17
|
|
pubmed:abstractText |
Relatives of patients with celiac disease have an increased lifetime risk of developing celiac disease. Repeat screening of relatives would improve diagnosis rates, but at significant cost. Genetic testing before screening would potentially reduce costs by eliminating HLA-DQ2 and DQ8 negative patients who are at extremely low risk for developing celiac disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1539-2031
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
43-50
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19020464-Celiac Disease,
pubmed-meshheading:19020464-Cost Control,
pubmed-meshheading:19020464-Decision Trees,
pubmed-meshheading:19020464-Family,
pubmed-meshheading:19020464-Genetic Testing,
pubmed-meshheading:19020464-HLA-DQ Antigens,
pubmed-meshheading:19020464-Humans,
pubmed-meshheading:19020464-Insurance, Health, Reimbursement,
pubmed-meshheading:19020464-Mass Screening,
pubmed-meshheading:19020464-Medicare,
pubmed-meshheading:19020464-Sensitivity and Specificity,
pubmed-meshheading:19020464-Serologic Tests,
pubmed-meshheading:19020464-Transglutaminases,
pubmed-meshheading:19020464-United States
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Genetic testing before serologic screening in relatives of patients with celiac disease as a cost containment method.
|
|
pubmed:affiliation |
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA.
|
|
pubmed:publicationType |
Journal Article
|
